Upregulation of miR-582-5p regulates cell proliferation and apoptosis by targeting AKT3 in human endometrial carcinoma

作者: Lingling Li , Li Ma

DOI: 10.1016/J.SJBS.2018.03.007

关键词:

摘要: The human endometrial carcinoma is one of the most common female malignancies, and there an urgent requirement to explore new therapeutic strategies. There accumulating evidence that microRNAs (miRNAs) can serve as potential diagnostic prognostic biomarkers for various types cancer, but significance miR-582-5p still remains largely unknown in carcinoma. aims this study were understand identify influence on proliferation apoptosis its relevant mechanism. First, quantitative real-time PCR (qRT-PCR) was used detect AKT3 expression tissue samples cells. Then, CyQuant assay 2D colony employed evaluate cell proliferation. Western blotting determine protein expression. Subsequently, luciferase reporter target miR-582-5p. Finally, Annexin V apoptosis. We found significantly decreased tissues, upregulation cells inhibit promote Moreover, validated a inversely correlated with Besides, efficiently abrogates effect These results demonstrated regulates via AKT3. Thus, represents meriting further investigation.

参考文章(25)
Yi Zhang, Wei Huang, Yan Ran, Yan Xiong, Zibiao Zhong, Xiaoli Fan, Zhenghua Wang, Qifa Ye, miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3 Tumor Biology. ,vol. 36, pp. 8309- 8316 ,(2015) , 10.1007/S13277-015-3582-0
Uwe Schirmer, Kai Doberstein, Anne-Kathleen Rupp, Niko P. Bretz, Daniela Wuttig, Helena Kiefel, Christian Breunig, Heidi Fiegl, Elisabeth Müller-Holzner, Robert Zeillinger, Eva Schuster, Alain G. Zeimet, Holger Sültmann, Peter Altevogt, Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma Oncotarget. ,vol. 5, pp. 462- 472 ,(2014) , 10.18632/ONCOTARGET.1552
Qinan Yin, Lara Fischer, Claudia Noethling, Wolfgang R. Schaefer, In vitro-assessment of putative antiprogestin activities of phytochemicals and synthetic UV absorbers in human endometrial Ishikawa cells. Gynecological Endocrinology. ,vol. 31, pp. 578- 581 ,(2015) , 10.3109/09513590.2015.1047448
Deborah A Altomare, Joseph R Testa, Perturbations of the AKT signaling pathway in human cancer Oncogene. ,vol. 24, pp. 7455- 7464 ,(2005) , 10.1038/SJ.ONC.1209085
Yongping Shao, Andrew E. Aplin, Akt3-Mediated Resistance to Apoptosis in B-RAF-Targeted Melanoma Cells Cancer Research. ,vol. 70, pp. 6670- 6681 ,(2010) , 10.1158/0008-5472.CAN-09-4471
Carlo M. Croce, Causes and consequences of microRNA dysregulation in cancer Nature Reviews Genetics. ,vol. 10, pp. 704- 714 ,(2009) , 10.1038/NRG2634
A Pagliuca, C Valvo, E Fabrizi, S di Martino, M Biffoni, D Runci, S Forte, R De Maria, L Ricci-Vitiani, Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression Oncogene. ,vol. 32, pp. 4806- 4813 ,(2013) , 10.1038/ONC.2012.495
Eva Gonzalez, Timothy E. McGraw, The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle. ,vol. 8, pp. 2502- 2508 ,(2009) , 10.4161/CC.8.16.9335
Hiroyuki Michiue, Akiko Eguchi, Miriam Scadeng, Steven F. Dowdy, Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma Cancer Biology & Therapy. ,vol. 8, pp. 2306- 2313 ,(2009) , 10.4161/CBT.8.23.10271
Keita Uchino, Fumitaka Takeshita, Ryou-u Takahashi, Nobuyoshi Kosaka, Kae Fujiwara, Haruna Naruoka, Satoru Sonoke, Junichi Yano, Hideo Sasaki, Shiari Nozawa, Miki Yoshiike, Kazuki Kitajima, Tatsuya Chikaraishi, Takahiro Ochiya, Therapeutic Effects of MicroRNA-582-5p and -3p on the Inhibition of Bladder Cancer Progression Molecular Therapy. ,vol. 21, pp. 610- 619 ,(2013) , 10.1038/MT.2012.269